FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileFirebrick Pharma Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Discussion
FRE.AX
Firebrick Pharma Limited Stock AnalysisComprehensive stock analysis for Firebrick Pharma Limited (FRE.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisFRE.AX
FRE.AX
Firebrick Pharma Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Discussion
FRE.AX
  1. Home
  2. Stocks
  3. Firebrick Pharma Limited

Firebrick Pharma Limited

🇦🇺FRE.AX•ASX

Firebrick Pharma Limited

🇦🇺FRE.AX•ASX

Your view on FRE.AX

Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Firebrick Pharma Limited

Industry
Drug Manufacturers - General
Sector
Healthcare
CEO
Peter Laurence Molloy
Headquarters
Level 14, Melbourne, VIC, AU
Industry
Drug Manufacturers - General
Sector
Healthcare
CEO
Peter Laurence Molloy
Headquarters
Level 14, Melbourne, VIC, AU
Description

Firebrick Pharma Limited, an enterprise established in 2012 and headquartered in Melbourne, Australia, is dedicated to the research, development, and market launch of Nasodine, a nasal spray treatment for the common cold, exclusively for the Australian market.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Firebrick Pharma Limited. Starting points for Firebrick Pharma Limited: EPS -AUD 0.01, beta 0.85 — an Drug Manufacturers - General name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Firebrick Pharma Limited. Firebrick Pharma Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Firebrick Pharma Limited. Trailing twelve-month EPS for Firebrick Pharma Limited stands at -AUD 0.01. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Firebrick Pharma Limited. Firebrick Pharma Limited has reported as a listed company since 2022. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold FRE.AX18 companies
Compare FRE.AX with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustry
AVE.AXAvecho Biotechnology LimitedHealthcareBiotechnology—
BTC.AXBTC Health LimitedHealthcareBiotechnology—
IMC.AXImmuron LimitedHealthcareBiotechnology—
IME.AXImExHS LimitedHealthcareMedical - Diagnostics & Research—
NC6.AXNanollose LimitedHealthcareBiotechnology—
NTI.AXNeurotech International LimitedHealthcareBiotechnology—
More Drug Manufacturers - General companies
TickerTypeCompanySectorExchangeMkt cap
SNYSanofiHealthcareNASDAQ$113.1B
SNYNFSanofiHealthcareOTC$115.1B
TGRNFTong Ren Tang Technologies Co. Ltd.HealthcareOTC$704.4M
VRBCFVirbac S.A.HealthcareOTC$2.9B
ABBVAbbVie Inc.HealthcareNYSE$505.5B
ALPMFAstellas Pharma Inc.HealthcareOTC$28.1B
ALPMYAstellas Pharma Inc.HealthcareOTC$29.2B
AMGNAmgen Inc.HealthcareNASDAQ$240.1B
AMRNAmarin Corporation plcHealthcareNASDAQ$232.9M
AZNAstraZeneca PLCHealthcareNYSE$277.2B
BAYRYBayer AGHealthcareOTC$49.0B
BIIBBiogen Inc.HealthcareNASDAQ$37.2B
Open Comparable Analysis
Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Firebrick Pharma Limited.

FRE.AX AnalysisFair
Past
1
Growth
5
Health
5
Profit
1
Value
1